SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $395,406 | +12.7% | 166,137 | +126.9% | 0.00% | – |
Q2 2023 | $350,776 | -43.8% | 73,231 | -33.5% | 0.00% | – |
Q1 2023 | $624,284 | -49.6% | 110,103 | -50.2% | 0.00% | – |
Q4 2022 | $1,238,994 | +441.0% | 221,249 | +518.5% | 0.00% | – |
Q3 2022 | $229,000 | +1808.3% | 35,773 | +887.7% | 0.00% | – |
Q2 2022 | $12,000 | -98.2% | 3,622 | -96.1% | 0.00% | – |
Q1 2022 | $668,000 | +1612.8% | 93,802 | +1913.4% | 0.00% | – |
Q4 2021 | $39,000 | -98.6% | 4,659 | -98.8% | 0.00% | -100.0% |
Q3 2021 | $2,755,000 | +1350.0% | 395,863 | +4861.9% | 0.00% | – |
Q2 2021 | $190,000 | +13.1% | 7,978 | -2.7% | 0.00% | – |
Q1 2021 | $168,000 | +281.8% | 8,198 | +355.4% | 0.00% | – |
Q4 2020 | $44,000 | -82.7% | 1,800 | -80.0% | 0.00% | – |
Q3 2020 | $255,000 | +8400.0% | 8,993 | +1184.7% | 0.00% | – |
Q2 2020 | $3,000 | -93.3% | 700 | -94.4% | 0.00% | – |
Q1 2020 | $45,000 | -67.6% | 12,533 | -68.9% | 0.00% | – |
Q4 2019 | $139,000 | +58.0% | 40,357 | +82.6% | 0.00% | – |
Q3 2019 | $88,000 | +2100.0% | 22,106 | +1600.5% | 0.00% | – |
Q2 2019 | $4,000 | -71.4% | 1,300 | -35.0% | 0.00% | – |
Q1 2019 | $14,000 | -6.7% | 2,000 | -37.0% | 0.00% | – |
Q4 2018 | $15,000 | +150.0% | 3,175 | +296.9% | 0.00% | – |
Q3 2018 | $6,000 | -75.0% | 800 | -71.4% | 0.00% | – |
Q2 2018 | $24,000 | +60.0% | 2,800 | +33.3% | 0.00% | – |
Q1 2018 | $15,000 | -42.3% | 2,100 | -19.2% | 0.00% | – |
Q4 2017 | $26,000 | -38.1% | 2,600 | 0.0% | 0.00% | – |
Q3 2017 | $42,000 | -26.3% | 2,600 | -48.9% | 0.00% | – |
Q2 2017 | $57,000 | -5.0% | 5,088 | -4.9% | 0.00% | – |
Q1 2017 | $60,000 | +93.5% | 5,348 | +73.1% | 0.00% | – |
Q4 2016 | $31,000 | -36.7% | 3,090 | -22.8% | 0.00% | – |
Q3 2016 | $49,000 | -3.9% | 4,003 | +128.4% | 0.00% | – |
Q2 2016 | $51,000 | +2.0% | 1,753 | -7.2% | 0.00% | – |
Q1 2016 | $50,000 | +31.6% | 1,888 | +76.6% | 0.00% | – |
Q4 2015 | $38,000 | – | 1,069 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |